| 1AV5 |
2.0 |
PKCI-SUBSTRATE ANALOG |
| 1KPA |
2.0 |
PKCI-1-ZINC |
| 1KPB |
2.0 |
PKCI-1-APO |
| 1KPC |
2.2 |
PKCI-1-APO+ZINC |
| 1KPE |
1.8 |
PKCI-TRANSITION STATE ANALOG |
| 1KPF |
1.5 |
PKCI-SUBSTRATE ANALOG |
| 3TW2 |
1.38 |
High resolution structure of human histidine triad nucleotide-binding protein 1 (hHINT1)/AMP complex in a monoclinic space group |
| 4EQE |
1.52 |
Crystal structure of histidine triad nucleotide-binding protein 1 (HINT1) from human complexed with Lys-AMS |
| 4EQG |
1.52 |
Crystal structure of histidine triad nucleotide-binding protein 1 (HINT1) from human complexed with Ala-AMS |
| 4EQH |
1.668 |
Crystal structure of histidine triad nucleotide-binding protein 1 (HINT1) from human complexed with Trp-AMS |
| 4ZKL |
2.34 |
Crystal structure of human histidine triad nucleotide-binding protein 1 (hHINT1) complexed with JB419 (AP4A analog) |
| 4ZKV |
1.92 |
Crystal structure of human histidine triad nucleotide-binding protein 1 (hHINT1) refined to 1.92A at P21 space group |
| 5ED3 |
1.309 |
crystal structure of human Hint1 complexing with AP5A |
| 5ED6 |
1.52 |
crystal structure of human Hint1 H114A mutant complexing with ATP |
| 5EMT |
1.5 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1)-copper complex |
| 5I2E |
1.6 |
Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound Sulfamate Inhibitor 3a:3-(5-O-{[3-(1H-indol-3-yl)propanoyl]sulfamoyl}-beta-D-ribofuranosyl)-3H-imidazo[2,1-i]purine |
| 5I2F |
1.25 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) with bound sulfamide inhibitor Bio-AMS |
| 5IPB |
1.55 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant |
| 5IPC |
1.3 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside thiophosphoramidate substrate complex |
| 5IPD |
1.75 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) nucleoside thiophosphoramidate covalent intermediate complex |
| 5IPE |
1.45 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) nucleoside thiophosphoramidate catalytic product complex |
| 5KLY |
1.3 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant adenosine nucleoside phosphoramidate substrate complex |
| 5KLZ |
1.5 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex |
| 5KM0 |
1.533 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint) IMP complex |
| 5KM1 |
1.65 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) GMP catalytic product complex |
| 5KM2 |
1.25 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) CMP catalytic product complex |
| 5KM3 |
1.2 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) UMP catalytic product complex |
| 5KM4 |
1.4 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1)-5-Iodo-UMP complex |
| 5KM6 |
1.6 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant Ara-A nucleoside phosphoramidate substrate complex |
| 5KMA |
1.55 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside D-Trp phosphoramidate substrate complex |
| 5KMB |
1.6 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside L-Trp phosphoramidate substrate complex |
| 5KMC |
1.35 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) non-nucleotidic covalent intermediate complex |
| 5O8I |
1.27 |
Crystal structure of human histidine triad nucleotide-binding protein 1 (hHINT1) crystallized at P212121 space group, and refined to 1.27 A |
| 5WA8 |
1.3 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside L-Ala phosphoramidate substrate complex |
| 5WA9 |
1.15 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside D-Ala phosphoramidate substrate complex |
| 5WAA |
1.098 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) C84R mutant |
| 6B42 |
1.13 |
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) 2'-deoxy-AMP complex at 1.13A resolution |
| 6G9Z |
1.43 |
Crystal structure of human histidine triad nucleotide-binding protein 1 (hHINT1) crystallized at P212121 space group, with visible extended fragment of N-terminus |
| 6J53 |
1.52 |
Crystal structure of human HINT1 complexing with ATP |
| 6J58 |
1.521 |
Crystal structure of human HINT1 complexing with AP4A |
| 6J5S |
1.02 |
Crystal structure of human HINT1 mutant complexing with AP5A |
| 6J5Z |
1.3 |
Crystal structure of human HINT1 mutant complexing with AP3A |
| 6J64 |
0.95 |
Crystal structure of human HINT1 mutant complexing with AP4A |
| 6J65 |
1.42 |
Crystal structure of human HINT1 mutant complexing with AP4A II |
| 6N3V |
1.45 |
Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[1-Ethyl]Carbamoyl Guanosine |
| 6N3W |
1.75 |
Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[3-Phenyl-1-Ethyl]Carbamoyl Guanosine |
| 6N3X |
1.1 |
Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[1-Benzyl]Carbamoyl Guanosine |
| 6N3Y |
1.8 |
Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[(3-Indolyl)-1-Ethyl]Carbamoyl Guanosine |
| 6YQM |
1.02 |
Human histidine triad nucleotide-binding protein 1 (hHINT1) complexed with dGMP and refined to 1.02 A |
| 7Q2U |
2.27 |
The crystal structure of the HINT1 Q62A mutant. |
